RSLS - エンテロメディックス （ReShape Lifesciences Inc.）

The following slide deck was published by ReShape Lifesciences Inc.

ReShape Lifesciences Inc. (NASDAQ:NASDAQ:RSLS) Q4 2022 Earnings Conference Call April 25, 2023 4:30 PM ETCompany ParticipantsMichael Miller - Investor RelationsPaul Hickey - President &…

ReShape Lifesciences press release (RSLS): FY Revenue of $11.24M (-17.9% Y/Y) misses by $2.24M.Net loss of $46.21M

Continued Sequential Quarterly Growth in the U.S. With Q4 Revenues of $2.7 Million Improved Operational Effectiveness With Second Half 2022 Operating Expenses Down 27.9% Compared to the First Half of 2022, A $5.1 Million Reduction Executing A Plan For Profitability With A Balance Sheet Bolstered By Approximately $16.0 Million Raised Over the Last 12 Months Conference Call to be Held at

ReShape Lifesciences (RSLS) shares dipped 9% on Thursday after the health solutions company priced an offering to raise $2.5M in gross proceeds.The firm entered into a securities…

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. JanOne Inc. (NASDAQ: JAN ) gained 66.5% to close at $3.73 after the company announced it sold GeoTraq to SPYR Technologies in a $13.5 million transaction. Mullen Automotive, Inc. (NASDAQ: MULN ) jumped 44.9% to settle at $1.40 after the company announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana. Studio City International Holdings Limited (NASDAQ: MSC ) gained 43.3% to close at $3.21. CatchMark Timber Trust, Inc. (NYSE: CTT ) shares climbed 42.1% to close at $11.79 after the company and PotlatchDeltic announced they have entered into a definitive agreement to combine in an all-stock transaction. Xcel Brands, Inc. (NASDAQ: XELB ) gained 36.7% to settle at $1.49 after the company announced WHP will purchase a controlling 70% interest in fashion brand Isaac Mizrahi.

Companies Reporting Before The Bell • Star Equity Hldgs (NASDAQ: STRR ) is expected to report quarterly loss at $0.15 per share on revenue of $25.45 million. • China Automotive Systems (NASDAQ: CAAS ) is estimated to report quarterly earnings at $0.07 per share on revenue of $126.27 million. • Niu Technologies (NASDAQ: NIU ) is likely to report earnings for its first quarter. • XPeng (NYSE: XPEV ) is likely to report quarterly loss at $0.28 per share on revenue of $1.09 billion. • Reshape Lifesciences (NASDAQ: RSLS ) is expected to report quarterly loss at $0.17 per share on revenue of $3.14 million. • Heliogen (NYSE: HLGN ) is projected to report quarterly loss at $0.06 per share on revenue of $5.24 million. • So-Young Intl (NASDAQ: SY ) is likely to report earnings for its first quarter. • QIWI (NASDAQ: QIWI ) is projected to report earnings for its first quarter. • Sonida Senior Living (NYSE: SNDA ) is projected to report quarterly loss at $4.84 per share on revenue … Full story available on Benzinga.

SAN CLEMENTE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced participation in the following investor conferences in March:

ReShape Lifesciences Inc. (RSLS) shares closed today at 0.7% above its 52 week low of $1.53, giving the company a market cap of $27M. The stock is currently down 6.1% year-to-date, down 64.8% over the past 12 months, and down 99.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 63.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 77.2% The company's stock price performance over the past 12 months lags the peer average by 595.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

The Bariatric Surgery Devices Market research report focuses on consolidations and acquisitions, extensions, examination of central participants, the foundation date of organization regions served, fabricating base, and income of vital participants. Moreover, the report also studies breakdown by product and

SAN CLEMENTE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced participation in the following investor conferences in March:

ReShape Lifesciences Inc. (RSLS) shares closed today at 0.7% above its 52 week low of $1.53, giving the company a market cap of $27M. The stock is currently down 6.1% year-to-date, down 64.8% over the past 12 months, and down 99.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 63.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 77.2% The company's stock price performance over the past 12 months lags the peer average by 595.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

The Bariatric Surgery Devices Market research report focuses on consolidations and acquisitions, extensions, examination of central participants, the foundation date of organization regions served, fabricating base, and income of vital participants. Moreover, the report also studies breakdown by product and

During the last session, ReShape Lifesciences Inc. (NASDAQ:RSLS)s traded shares were 1.16 million, with the beta value of the company hitting -1.09. At the end of the trading day, the stocks price was $2.09, reflecting an intraday gain of 5.03% or $0.1. The 52-week high for the RSLS share is $32.31, that puts it down After A 3.47% Jump In The Last Week, Does ReShape Lifesciences Inc. (NASDAQ: RSLS) Still Make Sense To Buy? Read More »

State Street Corp purchased a new position in ReShape Lifesciences Inc. (OTCMKTS:RSLS) in the second quarter, HoldingsChannel reports. The fund purchased 109,999 shares of the medical device companys stock, valued at approximately $550,000. Other hedge funds also recently added to or reduced their stakes in the company. Alpine Global Management LLC bought a new position []